Please See Full Prescribing Information, including BOXED WARNING, Medication Guide and Instructions for Use at Afrezza.com/Safety.
Important Safety Information
Afrezza® (insulin human) Inhalation Powder may cause serious side effects, including sudden lung problems (in a study, some AFREZZA-treated patients with asthma, whose asthma medication was temporarily withheld, experienced sudden lung problems). Other serious side effects may include low blood sugar, decreased lung function, lung cancer, diabetic ketoacidosis, severe allergic reaction, low potassium in your blood, and heart failure. Some of these side effects may lead to death. The most common side effects are low blood sugar, cough, and sore throat.
Don’t use AFREZZA if you have long-term lung problems such as asthma or chronic obstructive pulmonary disease (COPD) or are allergic to any of the ingredients in AFREZZA. Don’t use AFREZZA if you are having an episode of low blood sugar. Before starting AFREZZA, your healthcare provider will give you a breathing test to check how your lungs are working. AFREZZA is not for use to treat diabetic ketoacidosis. AFREZZA must be used with basal insulin in people who have type 1 diabetes. AFREZZA is not for use in people who smoke or have recently stopped smoking (less than 6 months). AFREZZA is used to control high blood sugar in adults with diabetes mellitus. Talk to your healthcare provider about all your medical conditions and medications.